Legal Counsel (Jean-Luc Elhoueiss) to the venture capital firm Leap Ventures Europe SAS in connection with the organisation of its first fund raising campaign.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a share capital increase of M€2.5 with a waiver of shareholders’ preferential subscription rights.
Legal Counsel (Jean-Luc Elhoueiss) to Pharnext in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a secondary offering of M€12 on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with the free distribution on Alternext of two lines of redeemable share subscription warrants (BSAR) in favour of all shareholders, for a maximum amount of M€28.7.
Legal Counsel (Jean-Luc Elhoueiss) to Pharnext in connection with the issue of a bond loan for a maximum amount of M€15.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a share capital increase of M€3, with a waiver of preferential subscription rights.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a secondary offering on Alternext via a share capital increase of M€5 with preferential subscription rights for shareholders.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a secondary offering on Alternext via a bond issue to be subscribed in cash or a public exchange offer of M€10.
Legal Counsel (Jean-Luc Elhoueiss) to 4T Commodities and Emerging Markets in connection with its formation.
Legal Counsel (Jean-Luc Elhoueiss) to Theraclion in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Pharnext in connection with the issue of a bond loan convertible into shares of an amount of M€10.6.
Legal Counsel (Jean-Luc Elhoueiss) to Abivax in connection with its creation via a contribution in kind of the shares of Splicos and Wittycell.
Legal Counsel (Jean-Luc Elhoueiss) to Auplata in connection with a secondary offering on Alternext through a share capital increase of M€5 with preferential subscription rights for shareholders.
Legal Counsel (Jean-Luc Elhoueiss) to Vexim in connection with a secondary offering on Alternext via a share capital increase with a waiver of shareholders’ preferential subscription rights in the form of a public offering of M€12, with the acquisition of an interest of M€5 by Bpi Participations.
Legal Counsel (Jean-Luc Elhoueiss) to Neovacs in connection with the implementation and drawdown of a contingent equity line with Kepler Cheuvreux.
Legal Counsel (Jean-Luc Elhoueiss) to Carbios in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Deinove in connection with the implementation and drawdown of a contingent equity line with Société Générale.
Legal Counsel (Jean-Luc Elhoueiss) to Vexim in connection with the implementation and drawdown of a contingent equity line with Société Générale.
Legal Counsel (Jean-Luc Elhoueiss) to Vexim in connection with a restricted share capital increase of M€2.5.
Legal Counsel (Jean-Luc Elhoueiss) to Theraclion in connection with the issuance of a bond loan convertible into shares of an amount of M€1.4.
Legal Counsel (Jean-Luc Elhoueiss) to Carmat in connection with the implementation and drawdown of a contingent equity line with Kepler Cheuvreux.
Legal Counsel (Jean-Luc Elhoueiss) to Neovacs in connection with a secondary offering on Alternext via a share capital increase of M€7.2 with preferential subscription rights for shareholders.
Legal Counsel (Jean-Luc Elhoueiss) to Theraclion in connection with a restricted share capital increase of M€1.65.
Legal Counsel (Jean-Luc Elhoueiss) to Melanion Capital, an asset management company specialised in investments in dividend futures, in connection with its incorporation.
Legal Counsel (Jean-Luc Elhoueiss) to Actility in connection with a restricted share capital increase of M€6.75.
Legal Counsel (Jean-Luc Elhoueiss) to Carbios in connection with a restricted share capital increase of M€3.3 in several tranches.
Legal Counsel (Jean-Luc Elhoueiss) to Pharnext in connection with restricted share capital increases for a total amount of M€13.
Legal Counsel (Jean-Luc Elhoueiss) to SP3H in connection with a restricted share capital increase of M€2.2.
Legal Counsel (Jean-Luc Elhoueiss) to Vexim in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Theraclion in connection with a restricted share capital increase of M€1.6.
Legal Counsel (Jean-Luc Elhoueiss) to Carmat in connection with a secondary offering on Alternext via a share capital increase of M€29.3 with preferential subscription rights for shareholders.
Legal Counsel (Jean-Luc Elhoueiss) to Neovacs in connection with a private placement of M€8 on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Vexim in connection with share capital increases of a total amount of M€8.
Legal Counsel (Jean-Luc Elhoueiss) to Pharnext in connection with restricted share capital increases of a total amount of M€10.5.
Legal Counsel (Jean-Luc Elhoueiss) to Carmat in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Deinove in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Neovacs in connection with its IPO on Alternext.
Legal Counsel (Jean-Luc Elhoueiss) to Truffle Capital, a venture capital firm that builds and invests in leading technological firms in the IT, life sciences and energy sectors, in connection with the launch of two public offerings entitled “2010 Incubator Holdings Series I” and “2010 Incubator Holdings Series II” involving the creation of sixteen holding companies known as “Holdings ISF”, under a single prospectus issued by the French securities market authority (AMF), for a financing round of a maximum amount of M€90.
Legal Counsel (Jean-Luc Elhoueiss) to the venture capital firm Truffle Capital in connection with a M€2.5 investment in shares in SP3H, a company specialised in fuel profiling.
Legal counsel (Erwan Cossé) to Ltkfarma during the investment made by many different private investors in the framework of the “TEPA”law.
Legal counsel (Erwan Cossé) to INL an innovative company that has designed and markets firewall authentication developed under Linux/Open Source, in the investment made by CM-CIC Capital Investissement and Cap Décisif investment funds.
Legal counsel (Erwan Cossé) to Axess Vision Technology at the investment made by OTC Asset Management and Cap Décisif investment funds.
Legal counsel (Jean-Luc Elhoueiss) to EADS and of the investment-fund Truffle Capital in connection with the creation of and investment in Carmat, an innovative high tech medical start-up stemming from the joint project of Professor Alain Carpentier, an internationally renowned surgeon, and EADS to develop biomaterials and leading-edge technologies for the manufacture of the first complete artificial heart implantable in the human body.
Legal counsel (Erwan Cossé) to Xentech an innovative company of medical research under contract (CRO) which offers services specializing in preclinical oncology, at the investment made by the investment fund Aurinvest Partners.
Legal counsel (Erwan Cossé) to Serial Genetics an innovative, medical research company under contract (CRO) that designed and markets diagnostic medical kits, in the investment made by the investment funds G1J Ile de France and Ixcore.
Legal counsel (Erwan Cossé) to Ltkfarma an innovative company of medical technology dedicated to the development of cell therapy products that facilitate transplants of hematopoietic stem cells for the treatment of leukemia and other severe forms of auto-immune diseases, at the investment made by several different private investors in the framework of the “TEPA” law.
Legal counsel (Jean-Luc Elhoueiss) to Novartis Venture Fund and to the investment fund Truffle Capital in connection with fund raising for Neovacs, a spin-off of University of Pierre and Marie Curie founded in 1993 by French immunologist Professor Daniel Zagury, focused on immunology and oncology and leader in the development of anti-cytokine and anti-viral regulatory protein therapeutic vaccines used in the treatment of certain cancers and certain inflammatory diseases.
Legal Counsel (Erwan Cossé) to Axess Vision Company, an innovative start-up company of advanced scientific technology dedicated to the conception and development of a flexible endoscope for single use, at the investment made by Solar Invest (investment firm- Capital Risk).
Legal counsel (Erwan Cossé) to Watchfrog, an innovative start-up company of advanced scientific technology dedicated to the conception and development of transgenic models for amphibians to detect in vivo chemical, pharmaceutical, and cosmetic pollutants in an investment made by the investment fund Cap Décisif.
Legal counsel (Erwan Cossé) to W4, a software editor dedicated to Business Processing Management (BPM) at an investment made by Seventure Partners, Odyssée Venture, Ace Management and Convergent Capital investment funds
Legal counsel (Erwan Cossé) to Dmailer, a start up company dedicated to the conception and development of synchronization software and backup for cell phones, at an investment made by BNP Paribas Private Equity and the investment fund Alto Invest.
Legal counsel (Jean-Luc Elhoueiss) to Truffle Capital and to Banexi Ventures Partners in connection with fund raising for Vexim, a company specialised in medical devices for the development and design of minimally invasive solutions for the treatment of the spine and, more precisely, spinal fractures by restoring the anatomy of the fractured vertebra.
Legal counsel (Jean-Luc Elhoueiss) to Drugabuse Sciences, a company specialised in therapies for the treatment of alcohol and drug addictions, in connection with the transfer of its assets to Elbion NV.
